Like in the mouse, CD4+ and CD8+ effector and effector memory T cells from BC CML patients had significantly increased PD-1 levels compared to their counterparts from CP CML patients (Supplementary Fig. 15j). The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.